Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma
CONCLUSIONS: Patient survival is poor and immune cell infiltration is abnormal when TYMP is highly expressed in ccRCC, suggesting that ccRCC patients could benefit from using TYMP as a molecular diagnostic and therapeutic target.PMID:38043946 | PMC:PMC10695089 | DOI:10.1177/15330338231194555
Source: Technology in Cancer Research and Treatment - Category: Cancer & Oncology Authors: Shao-An Chen Jun-Peng Zhang Ning Wang Ji Chen Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Immunotherapy | Kidney Cancer | Molecular Biology | Renal Cell Carcinoma